Nautilus Biotechnology, Inc. (NAUT)
USD 1.81
(-8.59%)
USD 1.81
(-8.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -51.71 Million | -45.8 Million | -39.24 Million | -13.99 Million | -9.66 Million | -238.29 Million |
| Net Income | -63.67 Million | -57.92 Million | -50.31 Million | -15.61 Million | -9.61 Million | 626.6 Million |
| Depreciation & Amortization | 5.7 Million | 3.41 Million | 2.84 Million | 2.34 Million | 548 Thousand | - |
| Deferred income taxes | -393 Thousand | - | - | - | 774.49 Thousand | - |
| Stock-based compensation | 12.13 Thousand | 10.38 Million | 7.93 Million | 369 Thousand | 110 Thousand | - |
| Change in working capital | -3.21 Million | -788 Thousand | -22 Thousand | -1.38 Million | -545 Thousand | 1.32 Million |
| Other non-cash items | -2.26 Million | -890 Thousand | 320 Thousand | 295 Thousand | -157 Thousand | -866.22 Million |
| Investing Cash Flow | -43.73 Million | -25.74 Million | -138.96 Million | -25.27 Million | 4.05 Million | 1.19 Million |
| Investments in PPE | -2.44 Million | -2.32 Million | -2.26 Million | -921 Thousand | -926 Thousand | - |
| Acquisitions | -71.59 Million | -163.17 Million | 136.69 Thousand | 24.35 Thousand | - | - |
| Investment purchases | -112.89 Million | -186.59 Million | -221.79 Million | -68.35 Million | - | - |
| Sales/Maturities of investments | 71.59 Million | 163.17 Million | 85.1 Million | 44 Million | - | - |
| Other Investing Activities | 71.59 Million | 163.17 Million | -136.69 Thousand | -24.35 Thousand | 4.97 Million | 1.19 Million |
| Financing Cash Flow | 368 Thousand | 562 Thousand | 327.44 Million | 75.89 Million | 36 Thousand | 145.18 Billion |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 264 Thousand | 232 Thousand | - | - | -874.32 Thousand | -1.19 Million |
| Common Stock Issuance | 368 Thousand | 562 Thousand | -7.96 Million | 75.89 Million | - | - |
| Other Financing Activities | 368 Thousand | 562 Thousand | 327.44 Million | 75.89 Million | 36 Thousand | 145.18 Billion |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 393 Thousand | -561 Thousand | 1.26 Million | 123 Thousand | 107.24 Thousand | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -393 Thousand | -227 Thousand | -1.28 Million | -1.51 Million | -545 Thousand | - |
| Cash at beginning of period | 115.47 Million | 186.46 Million | 37.21 Million | 595 Thousand | 1.19 Billion | - |
| Cash at end of period | 20.39 Million | 115.47 Million | 186.46 Million | 37.21 Million | 595 Thousand | 1.19 Million |
| Capital Expenditure | -2.44 Million | -2.32 Million | -2.26 Million | -921 Thousand | -926 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | 6171.00 | -144.94 Billion |
| Net cash flow / Change in cash | -95.07 Million | -70.98 Million | 149.24 Million | 36.62 Million | -1.19 Billion | 1.19 Million |
| Free Cash Flow | -54.15 Million | -48.13 Million | -41.51 Million | -14.91 Million | -10.58 Million | -238.29 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -16.44 Million | -18.01 Million | -18.73 Million | -63.67 Million | -17.02 Million | -15.87 Million |
| Depreciation & Amortization | 1.61 Million | 1.59 Million | 1.59 Million | 5.7 Million | 1.59 Million | 1.48 Million |
| Deferred income taxes | - | - | - | -393 Thousand | -1.72 Million | -627.55 Thousand |
| Stock-based compensation | 3.18 Million | 3.27 Million | 3.11 Million | 12.13 Million | 3.07 Million | 3.1 Million |
| Change in working capital | -740 Thousand | -1.62 Million | -1.49 Million | -3.21 Million | -920 Thousand | 179 Thousand |
| Other non-cash items | -723 Thousand | 6.17 Million | 5.45 Million | -2.26 Million | -619 Thousand | -449.00 |
| Investing Cash Flow | -7.5 Million | 14.29 Million | 22.35 Million | -43.73 Million | -41.06 Million | 13.07 Million |
| Investments in PPE | -709 Thousand | -512 Thousand | -647 Thousand | -2.44 Million | -413 Thousand | -874 Thousand |
| Acquisitions | - | - | - | -71.59 Million | 40.64 Thousand | -13.94 Thousand |
| Investment purchases | -43.7 Million | -15.69 Million | - | -112.89 Million | -60.99 Million | -5.05 Million |
| Sales/Maturities of investments | 36.91 Million | 30.5 Million | 23 Million | 71.59 Million | 20.35 Million | 19 Million |
| Other Investing Activities | 90.41 Million | 14.8 Million | 23 Thousand | 71.59 Million | -40.64 Thousand | 13.94 Thousand |
| Financing Cash Flow | 140 Thousand | 319 Thousand | 245 Thousand | 368 Thousand | 253 Thousand | 16 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 289 Thousand | - | - | 264 Thousand | 264 Thousand | - |
| Common Stock Issuance | -564 Thousand | 319 Thousand | 245 Thousand | 368 Thousand | 253 Thousand | 16 Thousand |
| Other Financing Activities | 140 Thousand | 319 Thousand | 245.00 | 368 Thousand | 253 Thousand | 16 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 273 Thousand | -402 Thousand | 94 Thousand | 393 Thousand | 371 Thousand | 221 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.01 Million | -1.21 Million | -1.58 Million | -393 Thousand | -1.29 Million | -42 Thousand |
| Cash at beginning of period | 25.88 Million | 25.72 Million | 19.39 Million | 115.47 Million | 75.1 Million | 73.75 Million |
| Cash at end of period | 5.41 Million | 24.88 Million | 25.72 Million | 20.39 Million | 20.39 Million | 75.1 Million |
| Capital Expenditure | -709 Thousand | -512 Thousand | -647 Thousand | -2.44 Million | -413 Thousand | -874 Thousand |
| Effect of forex changes on cash | - | - | - | - | -17.45 Million | -1.35 Million |
| Net cash flow / Change in cash | -20.47 Million | -844 Thousand | 6.33 Million | -95.07 Million | -54.7 Million | 1.35 Million |
| Free Cash Flow | -13.82 Million | -15.96 Million | -16.91 Million | -54.15 Million | -14.31 Million | -12.61 Million |
ABL
GFPT-R
PAH3
SMSI
FDX
300612